Literature DB >> 7743796

Meibomian gland dysfunction and tear film abnormalities in rosacea.

N Zengin1, H Tol, K Gündüz, S Okudan, S Balevi, H Endoğru.   

Abstract

In order to determine the relationship between meibomian gland dysfunction and tear film abnormalities in rosacea, tear film flow and stability and meibomian gland function were assessed in 43 consecutive patients. Schirmer, tear film break-up time, and meibomian gland function values in patients with ocular rosacea (n = 28) were found to be significantly decreased as compared with those of the patients with only cutaneous involvement and control patients (p > 0.05). In patients with dermatologic rosacea (n = 15) these values were not different from those of the age- and sex-matched controls (p > 0.05). The effects of tetracycline and meibomian gland expression therapy also were investigated in patients with ocular rosacea. Neither meibomian gland expression therapy nor tetracycline administration had beneficial effects on decreased tear secretion, but tetracycline improved the break-up time values. Our findings showed a positive relationship between tear film abnormalities and meibomian gland dysfunction in patients with rosacea. Decreased tear secretion in patients with ocular rosacea would seem to be a result of structural changes secondary to meibomian gland dysfunction, and short break-up time might be due to an abnormal meibum composition.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7743796

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  19 in total

1.  Topical azithromycin and oral doxycycline therapy of meibomian gland dysfunction: a comparative clinical and spectroscopic pilot study.

Authors:  Gary N Foulks; Douglas Borchman; Marta Yappert; Shelley Kakar
Journal:  Cornea       Date:  2013-01       Impact factor: 2.651

2.  Is optical coherence tomography an effective device for evaluation of tear film meniscus in patients with acne rosacea?

Authors:  F C Eroglu; A Karalezli; R Dursun
Journal:  Eye (Lond)       Date:  2016-01-15       Impact factor: 3.775

3.  Performance profile of sodium hyaluronate in patients with lipid tear deficiency: randomised, double-blind, controlled, exploratory study.

Authors:  P Prabhasawat; N Tesavibul; N Kasetsuwan
Journal:  Br J Ophthalmol       Date:  2006-09-14       Impact factor: 4.638

4.  Meibography: A review of techniques and technologies.

Authors:  Ryan J Wise; Rachel K Sobel; Richard C Allen
Journal:  Saudi J Ophthalmol       Date:  2012-10

Review 5.  The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD.

Authors:  Debra A Schaumberg; Jason J Nichols; Eric B Papas; Louis Tong; Miki Uchino; Kelly K Nichols
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

Review 6.  The international workshop on meibomian gland dysfunction: report of the subcommittee on tear film lipids and lipid-protein interactions in health and disease.

Authors:  Kari B Green-Church; Igor Butovich; Mark Willcox; Douglas Borchman; Friedrich Paulsen; Stefano Barabino; Ben J Glasgow
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

Review 7.  Dysfunctional tear syndrome: dry eye disease and associated tear film disorders - new strategies for diagnosis and treatment.

Authors:  Mark S Milner; Kenneth A Beckman; Jodi I Luchs; Quentin B Allen; Richard M Awdeh; John Berdahl; Thomas S Boland; Carlos Buznego; Joseph P Gira; Damien F Goldberg; David Goldman; Raj K Goyal; Mitchell A Jackson; James Katz; Terry Kim; Parag A Majmudar; Ranjan P Malhotra; Marguerite B McDonald; Rajesh K Rajpal; Tal Raviv; Sheri Rowen; Neda Shamie; Jonathan D Solomon; Karl Stonecipher; Shachar Tauber; William Trattler; Keith A Walter; George O Waring; Robert J Weinstock; William F Wiley; Elizabeth Yeu
Journal:  Curr Opin Ophthalmol       Date:  2017-01       Impact factor: 3.761

8.  [Meibomian glands : part III. Dysfunction - argument for a discrete disease entity and as an important cause of dry eye].

Authors:  E Knop; N Knop; H Brewitt; U Pleyer; P Rieck; B Seitz; F Schirra
Journal:  Ophthalmologe       Date:  2009-11       Impact factor: 1.059

9.  Concordance between common dry eye diagnostic tests.

Authors:  J E Moore; J E Graham; E A Goodall; D A Dartt; A Leccisotti; V E McGilligan; T C B Moore
Journal:  Br J Ophthalmol       Date:  2008-09-09       Impact factor: 4.638

10.  Short-term effects of topical cyclosporine A 0.05% (Restasis) in long-standing prosthetic eye wearers: a pilot study.

Authors:  J W Han; J S Yoon; S Y Jang
Journal:  Eye (Lond)       Date:  2014-08-01       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.